{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:23:53Z","timestamp":1784622233944,"version":"3.55.0"},"reference-count":36,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:p>A lipodistrofia associada ao HIV (LAHIV) acomete 40% a 50% dos pacientes infectados pelo v\u00edrus, mas sua preval\u00eancia no Brasil \u00e9 desconhecida. O objetivo deste trabalho foi avaliar a preval\u00eancia de LAHIV entre adultos brasileiros infectados, bem como sua rela\u00e7\u00e3o com fatores de risco cardiovascular e s\u00edndrome metab\u00f3lica (SM). Foram avaliados 180 pacientes maiores de 18 anos, infectados por HIV, atendidos no Ambulat\u00f3rio de Infectologia da Universidade Estadual de Londrina. Por meio de entrevista e revis\u00e3o de prontu\u00e1rio, foram avaliados dados antropom\u00e9tricos, press\u00e3o arterial, antecedentes m\u00f3rbidos pessoais e familiares, dura\u00e7\u00e3o da infec\u00e7\u00e3o por HIV e da aids, drogas anti-retrovirais utilizadas, CD4+, carga viral, glicemia e perfil lip\u00eddico. A LAHIV foi definida como a presen\u00e7a de altera\u00e7\u00f5es corporais percebidas pelo pr\u00f3prio paciente e confirmadas ao exame cl\u00ednico. A SM foi diagnosticada usando os crit\u00e9rios do Adult Treatment Panel III (NCEP-ATPIII), revistos e atualizados pela American Heart Association (AHA\/NHLBI). A preval\u00eancia observada de LAHIV foi de 55%. Os pacientes com LAHIV apresentaram maior dura\u00e7\u00e3o da infec\u00e7\u00e3o por HIV, da aids e do uso de anti-retrovirais. Na an\u00e1lise multivariada, estiveram independentemente associados ao risco de LAHIV: sexo feminino (p = 0,006) e dura\u00e7\u00e3o da aids &gt; 8 anos (p &lt; 0,001). Quanto aos crit\u00e9rios para SM, hipertens\u00e3o foi detectada em 32%, baixo HDL-colesterol em 68%, hipertrigliceridemia em 55%, cintura aumentada em 17% e glicemia aumentada e\/ou diabetes em 23% dos indiv\u00edduos. A cintura aumentada e a hipertrigliceridemia foram mais comuns em portadores de LAHIV. A SM foi identificada em 36% dos pacientes. Na an\u00e1lise multivariada, estiveram associados \u00e0 SM: IMC &gt; 25 kg\/m\u00b2 (p &lt; 0,001), hist\u00f3ria familiar de obesidade (p = 0,01), uso de indinavir (p = 0,001) e idade &gt; 40 anos no diagn\u00f3stico do HIV (p = 0,002). A LAHIV apresentou tend\u00eancia a ser mais comum em portadores de SM (65% versus 50%, p = 0,051). A preval\u00eancia de LAHIV que se observou neste grupo (55%) foi similar \u00e0 descrita em estudos pr\u00e9vios de outros pa\u00edses. A preval\u00eancia de SM nestes pacientes parece ser diferente da descrita em adultos brasileiros n\u00e3o-infectados pelo HIV.<\/jats:p>","DOI":"10.1590\/s0004-27302008000400012","type":"journal-article","created":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T02:34:21Z","timestamp":1215138861000},"page":"658-667","source":"Crossref","is-referenced-by-count":39,"title":["Preval\u00eancia da lipodistrofia associada ao HIV em pacientes ambulatoriais brasileiros: rela\u00e7\u00e3o com s\u00edndrome metab\u00f3lica e fatores de risco cardiovascular"],"prefix":"10.1590","volume":"52","author":[{"given":"Leandro A.","family":"Diehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana\u00edna R.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline C. S.","family":"Paes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Thomazini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena R.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Cinagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana L.","family":"Wiechmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre J. F.","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan C","year":"2001","journal-title":"Clin Infect Dis."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected patients","volume":"351","author":"Grinspoon S","year":"2005","journal-title":"N Engl J Med."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/00002030-200304001-00017","article-title":"HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management","volume":"17","author":"Carr A.","year":"2003","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/01.aids.0000191485.92285.c7","article-title":"Self-perception of body changes in persons living with HIV\/AIDS: prevalence and associated factors","volume":"19","author":"Santos CP","year":"2005","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy SM","year":"2005","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.metabol.2006.02.024","article-title":"Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy","volume":"55","author":"Estrada V","year":"2006","journal-title":"Metab Clin Exp"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2337\/diacare.28.1.132","article-title":"Metabolic syndrome among HIV-infected patients","volume":"28","author":"Jeric\u00f3 C","year":"2005","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QAI.0b013e318074ef83","article-title":"HIV and metabolic syndrome: a comparison with the general population","volume":"45","author":"Bonfanti P","year":"2007","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome: a new worldwide definition","volume":"366","author":"Alberti KGMM","year":"2005","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref11","series-title":"Estimativa de preval\u00eancia do HIV na popula\u00e7\u00e3o brasileira de 15 a 49 anos","year":"2004"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","article-title":"Lipodystrophy in human immunodeficiency virus-infected patients","volume":"87","author":"Chen D","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"ref13","series-title":"Estimativa da popula\u00e7\u00e3o: 2004"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular risk factors in HIV patients: association with antiretroviral therapy","volume":"17","author":"Friis-M\u00f8ller N","year":"2003","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group: Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-M\u00f8ller N","year":"2003","journal-title":"N Engl J Med."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jc.2002-021704","article-title":"Human immunodeficiency virus\/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies","volume":"88","author":"Leow MKS","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study","volume":"357","author":"Martinez E","year":"2001","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref18","first-page":"199","article-title":"Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active antiretroviral therapy regimens in Western India","volume":"39","author":"Pujari SN","year":"2005","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00126334-200308150-00004","article-title":"An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score","volume":"33","author":"Carr A","year":"2003","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1590\/S0004-27302005000600004","article-title":"Altera\u00e7\u00f5es metab\u00f3licas da s\u00edndrome lipodistr\u00f3fica do HIV","volume":"49","author":"Valente AMM","year":"2005","journal-title":"Arq Bras Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0004-2730","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein KA","year":"2001","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.289.22.2978","article-title":"Impact of HIV infection and HAART on serum lipids in men","volume":"289","author":"Riddler SA","year":"2003","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2005.04.013","article-title":"Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients","volume":"184","author":"Asztalos BF","year":"2005","journal-title":"Atherosclerosis","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9150","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1097\/00002030-200110190-00018","article-title":"Getting to the HAART of insulin resistance","volume":"15","author":"Nolan D","year":"2001","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/QAI.0b013e318031d7e3","article-title":"A comparison of factors associated with prevalent diabetes mellitus among HIV-infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort","volume":"45","author":"Brar I","year":"2007","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref26","series-title":"Estudo multic\u00eantrico sobre a preval\u00eancia do diabete melito no Brasil","year":"1988"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1590\/S0004-27302007000100008","article-title":"Distribui\u00e7\u00e3o da gordura corporal e perfis lip\u00eddico e glic\u00eamico de pacientes infectados pelo HIV","volume":"51","author":"Guimar\u00e3es MMM","year":"2007","journal-title":"Arq Bras Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0004-2730","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1590\/S0004-27302006000300008","article-title":"Preval\u00eancia de s\u00edndrome metab\u00f3lica em uma \u00e1rea rural do semi-\u00e1rido baiano","volume":"50","author":"Oliveira EP","year":"2006","journal-title":"Arq Bras Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0004-2730","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00126334-200211010-00015","article-title":"High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk","volume":"31","author":"Bruno R","year":"2002","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/dc06-1075","article-title":"Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III Criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia","volume":"30","author":"Samaras K","year":"2007","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/511679","article-title":"Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population","volume":"44","author":"Mondy K","year":"2007","journal-title":"Clin Infect Dis."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies","volume":"49","author":"Gami AS","year":"2007","journal-title":"J Am Coll Cardiol","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2005.09.073","article-title":"Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients","volume":"47","author":"van Wijk JPH","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.qai.0000219775.20174.2d","article-title":"Metabolic syndrome: a real threat for HIV-positive patients? Results from the SIMONE Study","volume":"42","author":"Bonfanti P","year":"2006","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","article-title":"Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study","volume":"16","author":"Noor MA","year":"2002","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy","volume":"275","author":"Murata H","year":"2000","journal-title":"J Biol Chem."}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v52n4\/a12v52n4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T09:28:35Z","timestamp":1557653315000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302008000400012&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0004-27302008000400012"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302008000400012","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}